D. Priebat

发表

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

P. Thall, J. Wathen, D. Reinke, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma

E. Stepanski, M. Milhem, D. Priebat, 2017, Cancer.

Survival After Induction Chemotherapy and Surgical Resection for High-Grade Soft Tissue Sarcoma. Is Radiation Necessary?

B. Shmookler, D. Priebat, R. Henshaw, 2001, Annals of Surgical Oncology.

Activity of imatinib mesylate in desmoid tumors: Interim analysis of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial.

P. Thall, R. Maki, R. Benjamin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A SARC phase II multicenter trial of imatinib mesylate (IM) in patients with aggressive fibromatosis.

J. Wathen, D. Reinke, R. Maki, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Doxorubicin-Induced Cardiac Toxicity and Cardiac Rest Gated Blood Pool Imaging

D. Nostrand, E. Acio, M. Aiken, 2009, Clinical nuclear medicine.

997 GRANULOCYTE TRANSFUSIONS (GT) INCREASE SURVIVAL IN NEONATES WITH SEPSIS AND NEUTROPHIL DEPLETION

D. Priebat, R. Christensen, G. Rothstein, 1981, Pediatric Research.

Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARC028—A multicenter phase II study.

S. D'Angelo, H. Tawbi, M. Burgess, 2016 .

Follicular Dendritic Cell Sarcoma of the Neck: Case Report and Review of Current Diagnostic and Management Strategies

L. Amiri-Kordestani, D. Priebat, S. Chia, 2010, Ear, nose, & throat journal.

Granulocyte Transfusion in Septic Canine Neonates

D. Priebat, R. Christensen, G. Rothstein, 1982, Pediatric Research.

Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

D. Priebat, R. Christensen, G. Rothstein, 1982, The Journal of investigative dermatology.

Survival After Induction Chemotherapy and Surgical Resection for High-Grade Extremity Sarcoma . Is Radiation Necessary ?

B. Shmookler, D. Priebat, R. Henshaw, 2003 .

Adult acute leukemia. Aggressive treatment improves survival

J. Ward, D. Priebat, Harmon J. Eyre, 1983, Cancer.

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

J. Wargo, H. Tawbi, E. Keung, 2020, Clinical Cancer Research.

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

J. Crowley, I. Wistuba, H. Tawbi, 2017, The Lancet. Oncology.

Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

Paul A Meyers, Laurence H Baker, J Kyle Wathen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

P. Thall, J. Wathen, D. Reinke, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.

B. Shmookler, D. Priebat, M. Malawer, 2002, American family physician.

The Role of Chemotherapy in the Treatment of Bone and Soft-tissue Sarcomas

D. Priebat, M. Malawer, 2004 .

Phase II trial of gemcitabine in patients with advanced sarcomas (E1797)

J. Edmonson, S. Okuno, D. Priebat, 2003, Cancer.

Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib

Dafydd G. Thomas, V. Bolejack, D. Reinke, 2018, JAMA oncology.

Chemotherapy and Other Systemic Approaches to Adult Sarcomas

D. Priebat, 2017 .

Splenosis mimicking an intra-abdominal malignancy.

D. Priebat, J. White, A. West, 1989, The American journal of medicine.

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

J. Wathen, R. Maki, S. George, 2013, Cancer.

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

Dafydd G. Thomas, J. Wathen, R. Maki, 2010, Clinical Cancer Research.

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

J. Crowley, K. Owzar, J. Fletcher, 2017, JAMA oncology.

Adjuvant treatment of high-risk primary uterine leiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D): Results of phase II multicenter trial SARC005.

R. Maki, S. George, G. Sutton, 2010 .

Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.

H. Tawbi, E. Keung, M. Burgess, 2019, Journal of Clinical Oncology.

Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy.

D. Priebat, T. Allweis, N. Dubin, 2002, American journal of surgery.

Impact of two cycles of preoperative chemotherapy with intraarterial cisplatin and intravenous doxorubicin on the choice of surgical procedure for high-grade bone sarcomas of the extremities.

G. Reaman, B. Shmookler, D. Priebat, 1991, Clinical orthopaedics and related research.

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

D. Priebat, A. Sherker, Shilen V. Lakhani, 2008, Hepatology international.

Current Imaging and Therapy of Malignant Soft Tissue Tumors and Tumor-like Lesions

F. Beaman, D. Priebat, J. Jelinek, 2013, Seminars in Musculoskeletal Radiology.

SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas.

H. Tawbi, M. Burgess, D. Reinke, 2015 .

Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033.

K. Owzar, J. Fletcher, G. Demetri, 2014 .

A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS).

P. Thall, J. Wathen, D. Reinke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses.

H. Tawbi, L. Butterfield, M. Burgess, 2017 .

Imatinib mesylate in soft tissue and bone sarcomas: Interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial.

P. Thall, R. Benjamin, L. Baker, 2004, Journal of Clinical Oncology.

The Neutrophil Response to Polyvinyl Sponge Implantation 1

D. Priebat, R. Christensen, G. Rothstein, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

J. Wathen, R. Maki, S. George, 2013, Cancer.